Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Aclaris Therapeutics (ACRS) Return on Assets (2017 - 2025)

Historic Return on Assets for Aclaris Therapeutics (ACRS) over the last 9 years, with Q3 2025 value amounting to 0.8%.

  • Aclaris Therapeutics' Return on Assets fell 5700.0% to 0.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8%, marking a year-over-year decrease of 5700.0%. This contributed to the annual value of 0.63% for FY2024, which is 2400.0% down from last year.
  • According to the latest figures from Q3 2025, Aclaris Therapeutics' Return on Assets is 0.8%, which was down 5700.0% from 0.71% recorded in Q2 2025.
  • Over the past 5 years, Aclaris Therapeutics' Return on Assets peaked at 0.21% during Q2 2021, and registered a low of 0.8% during Q3 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.35% (2024), whereas its average is 0.42%.
  • As far as peak fluctuations go, Aclaris Therapeutics' Return on Assets skyrocketed by 3100bps in 2024, and later crashed by -5700bps in 2025.
  • Aclaris Therapeutics' Return on Assets (Quarter) stood at 0.35% in 2021, then increased by 1bps to 0.34% in 2022, then fell by -30bps to 0.45% in 2023, then tumbled by -49bps to 0.67% in 2024, then decreased by -20bps to 0.8% in 2025.
  • Its Return on Assets was 0.8% in Q3 2025, compared to 0.71% in Q2 2025 and 0.64% in Q1 2025.